Trans-resveratrol induces a potential anti-lipogenic effect in lipopolysaccharide-stimulated enterocytes

Cellular and Molecular Biology

Volumn 61, Issue 8, 2015, Pages 9-16

  Etxeberria, U ^a   Castilla Madrigal, R ^a   Lostao, M P ^a,c   Martinez, J A ^a,b,c   Milagro, F I ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c IdiSNA Navarra Institute for Health Research   (Spain)

Author keywords

Enterocytes; Gut; In vitro; Inflammation; Lipid metabolism; Resveratrol

Indexed keywords

AMPHIREGULIN; CHOLESTEROL; GLYCOPROTEIN; HISTIDINE RICH GLYCOPROTEIN; INHIBITOR OF DIFFERENTIATION 1; KRUPPEL LIKE FACTOR 5; LIPOPOLYSACCHARIDE; LONG CHAIN FATTY ACID COENZYME A LIGASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; RESVERATROL; SPROUTY PROTEIN; STILBENE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; AREG PROTEIN, HUMAN; COENZYME A LIGASE; EPIDERMAL GROWTH FACTOR DERIVATIVE; HISTIDINE-RICH PROTEINS; HYPOCHOLESTEROLEMIC AGENT; ID1 PROTEIN, HUMAN; KLF5 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; LIPG PROTEIN, HUMAN; LONG-CHAIN-FATTY-ACID-COA LIGASE; MEMBRANE PROTEIN; NOX1 PROTEIN, HUMAN; PHOSPHOPROTEIN; PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SPRY1 PROTEIN, HUMAN; STILBENE DERIVATIVE;

ACSL3 GENE; AREG GENE; ARTICLE; CACO 2 CELL LINE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE; GENE EXPRESSION; HRG GENE; HUMAN; HUMAN CELL; ID1 GENE; INTESTINE CELL; KLF5 GENE; LIPG GENE; LIPID METABOLISM; LIPOGENESIS; NOX1 GENE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SPRY GENE; UPREGULATION; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROARRAY ANALYSIS; SIGNAL TRANSDUCTION;

ANTICHOLESTEREMIC AGENTS; CACO-2 CELLS; CELL DEATH; CHOLESTEROL; COENZYME A LIGASES; EGF FAMILY OF PROTEINS; ENTEROCYTES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIPASE; LIPOGENESIS; LIPOPOLYSACCHARIDES; MEMBRANE PROTEINS; MICROARRAY ANALYSIS; NADPH OXIDASE; PHOSPHOPROTEINS; PROTEINS; SIGNAL TRANSDUCTION; STILBENES;

EID: 84962148729     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.14715/cmb/2015.61.8.2     Document Type: Article

References (69)

1. Peterson, L.W. and Artis, D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol. 2014, 14: 141-53. doi: 10.1038/nri3608.
2. Romier, B., Schneider, Y.J., Larondelle, Y. and During, A. Dietary polyphenols can modulate the intestinal inflammatory response. Nutr Rev. 2009, 67: 363-78. doi: 10.1111/j.1753-4887.2009.00210.x.
3. Azuma, T., Shigeshiro, M., Kodama, M., Tanabe, S. and Suzuki, T. Supplemental naringenin prevents intestinal barrier defects and inflammation in colitic mice. J Nutr. 2013, 143: 827-34. doi: 10.3945/jn.113.174508.
4. Martin, G.R. and Wallace, JL. Gastrointestinal inflammation: a central component of mucosal defense and repair. Exp Biol Med (Maywood). 2006, 231: 130-7.
5. Van De Walle, J., Hendrickx, A., Romier, B., Larondelle, Y. and Schneider, YJ. Inflammatory parameters in Caco-2 cells: effect of stimuli nature, concentration, combination and cell differentiation. Toxicol In Vitro. 2010, 24: 1441-9. doi: 10.1016/j.tiv.2010.04.002.
6. Brown, K., DeCoffe, D., Molcan, E. and Gibson, DL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients. 2012, 4: 1095-119. doi: 10.3390/nu4081095.
7. Kless, C., Muller, V.M., Schuppel, V.L., Lichtenegger, M., Rychlik, M., Daniel, H., Klingenspor, M. and Haller, D. Diet-induced obesity causes metabolic impairment independent of alterations in gut barrier integrity. Mol Nutr Food Res. 2015, 59: 968-78. doi: 10.1002/mnfr.201400840.
8. de La Serre, C.B., Ellis, C.L., Lee, J., Hartman, A.L., Rutledge, J.C. and Raybould, HE. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol. 2010, 299: G440-8. doi: 10.1002/mnfr.201400840.
9. Bondia-Pons, I., Ryan, L. and Martinez, JA. Oxidative stress and inflammation interactions in human obesity. J Physiol Biochem. 2012, 68: 701-11. doi: 10.1007/s13105-012-0154-2.
10. Laakso, M. Cardiovascular Disease in Type 2 Diabetes From Population to Man to Mechanisms: The Kelly West Award Lecture 2008. Diabetes Care. 2010, 33: 442-9. doi: 10.2337/dc09-0749.
11. Carpene, C., Gomez-Zorita, S., Deleruyelle, S. and Carpene, MA. Novel strategies for preventing diabetes and obesity complications with natural polyphenols. Curr Med Chem. 2015, 22: 150-64. doi: 10.2174/0929867321666140815124052.
12. Aguirre, L., Fernandez-Quintela, A., Arias, N. and Portillo, MP. Resveratrol: anti-obesity mechanisms of action. Molecules. 2014, 19: 18632-55. doi: 10.3390/molecules191118632.
13. Riccioni, G., Gammone, M.A., Tettamanti, G., Bergante, S., Pluchinotta, F.R. and D'Orazio, N. Resveratrol and anti-atherogenic effects. Int J Food Sci Nutr. 2015, 66: 603-10. doi: 10.3109/09637486.2015.1077796.
14. Ramprasath, V.R. and Jones, PJ. Anti-atherogenic effects of resveratrol. Eur J Clin Nutr. 2010, 64: 660-8. doi: 10.1038/ejcn.2010.77.
15. Bereswill, S., Munoz, M., Fischer, A., Plickert, R., Haag, L.M., Otto, B., Kuhl, A.A., Loddenkemper, C., Gobel, U.B. and Heimesaat, MM. Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS One. 2010, 5: e15099. doi: 10.1371/journal.pone.0015099.
16. Kaldas, M.I., Walle, U.K. and Walle, T. Resveratrol transport and metabolism by human intestinal Caco-2 cells. J Pharm Pharmacol. 2003, 55: 307-12.
17. Carrasco-Pozo, C., Morales, P. and Gotteland, M. Polyphenols protect the epithelial barrier function of Caco-2 cells exposed to indomethacin through the modulation of occludin and zonula occludens-1 expression. J Agric Food Chem. 2013, 61: 5291-7. doi: 10.1021/jf400150p.
18. Lu, Y.C., Yeh, W.C. and Ohashi, PS. LPS/TLR4 signal transduction pathway. Cytokine. 2008, 42: 145-51. doi: 10.1016/j.cyto.2008.01.006.
19. Boutagy, N.E., McMillan, R.P., Frisard, M.I. and Hulver, MW. Metabolic endotoxemia with obesity: Is it real and is it relevant? Biochimie. 2015; doi:10.1016/j.biochi.2015.06.020. doi: 10.1016/j.biochi.2015.06.020.
20. Pussinen, P.J., Tuomisto, K., Jousilahti, P., Havulinna, A.S., Sundvall, J. and Salomaa, V. Endotoxemia, immune response to peri odontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol. 2007, 27: 1433-9. doi: 10.1161/ATVBAHA.106.138743.
21. Martinez, J.A., Etxeberria, U., Galar, A. and Milagro, FI. Role of dietary polyphenols and inflammatory processes on disease progression mediated by the gut microbiota. Rejuvenation Res. 2013, 16: 435-7. doi: 10.1089/rej.2013.1481.
22. Wang, W., Xia, T. and Yu, X. Wogonin suppresses inflammatory response and maintains intestinal barrier function via TLR4-MyD88-TAK1-mediated NF-kappaB pathway in vitro. Inflamm Res. 2015, 64: 423-31. doi: 10.1007/s00011-015-0822-0.
23. Cianciulli, A., Calvello, R., Cavallo, P., Dragone, T., Carofiglio, V. and Panaro, MA. Modulation of NF-kappaB activation by resveratrol in LPS treated human intestinal cells results in downregulation of PGE2 production and COX-2 expression. Toxicol In Vitro. 2012, 26: 1122-8. doi: 10.1016/j.tiv.2012.06.015.
24. Scalbert, A. and Williamson, G. Dietary intake and bioavailability of polyphenols. J Nutr. 2000, 130: 2073S-85S.
25. Irizarry, R.A., Bolstad, B.M., Collin, F., Cope, L.M., Hobbs, B. and Speed, TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003, 31: e15.
26. Gentleman, R., Carey, V., Huber, W., Irizarry, R. and Dudoit, S. Bioinformatics and computational biology solutions using R and Bioconductor. Springer Science & Business Media; 2006.
27. Smyth, G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004, 3: Article3. doi: 10.2202/1544-6115.1027.
28. Draghici, S. Data analysis tools for DNA microarrays. Chapman & Hall/CRC mathematical biology and medicine series Show all parts in this series. 2003.
29. Livak, K.J. and Schmittgen, TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25: 402-8. doi: 10.1006/meth.2001.1262.
30. Rodriguez-Hernandez, H., Simental-Mendia, L.E., Rodriguez-Ramirez, G. and Reyes-Romero, MA. Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. Int J Endocrinol. 2013, 2013: 678159. doi: 10.1155/2013/678159.
31. Perreault, M., Zulyniak, M.A., Badoud, F., Stephenson, S., Badawi, A., Buchholz, A. and Mutch, DM. A distinct fatty acid profile underlies the reduced inflammatory state of metabolically healthy obese individuals. PLoS One. 2014, 9: e88539. doi: 10.1371/journal.pone.0088539.
32. Strable, M.S. and Ntambi, JM. Genetic control of de novo lipogenesis: role in diet-induced obesity. Crit Rev Biochem Mol Biol. 2010, 45: 199-214. doi: 10.3109/10409231003667500.
33. Capel, F., Acquaviva, C., Pitois, E., Laillet, B., Rigaudiere, J.P., Jouve, C., Pouyet, C., Gladine, C., Comte, B., Vianey Saban, C. and Morio, B. DHA at nutritional doses restores insulin sensitivity in skeletal muscle by preventing lipotoxicity and inflammation. J Nutr Biochem. 2015, 26: 949-59. doi: 10.1016/j.jnutbio.2015.04.003.
34. Vanamala, J., Reddivari, L., Radhakrishnan, S. and Tarver, C. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer. 2010, 10: 238. doi: 10.1186/1471-2407-10-238.
35. Gatz, S.A. and Wiesmuller, L. Take a break--resveratrol in action on DNA. Carcinogenesis. 2008, 29: 321-32. doi: 10.1186/1471-2407-10-238.
36. Ma, J., Shi, M., Li, G., Wang, N., Wei, J., Wang, T. and Wang, Y. Regulation of Id1 expression by epigallocatechin3gallate and its effect on the proliferation and apoptosis of poorly differentiated AGS gastric cancer cells. Int J Oncol. 2013, 43: 1052-8. doi: 10.3892/
37. Johnson, L.D., Goubran, H.A. and Kotb, RR. Histidine rich glycoprotein and cancer: a multi-faceted relationship. Anticancer Res. 2014, 34: 593-603.
38. Fu, X.J., Peng, Y.B., Hu, Y.P., Shi, Y.Z., Yao, M. and Zhang, X. NADPH oxidase 1 and its derived reactive oxygen species mediated tissue injury and repair. Oxid Med Cell Longev. 2014, 2014: 282854. doi: 10.1155/2014/282854.
39. Park, D.W., Baek, K., Kim, J.R., Lee, J.J., Ryu, S.H., Chin, B.R. and Baek, SH. Resveratrol inhibits foam cell formation via NADPH oxidase 1- mediated reactive oxygen species and monocyte chemotactic protein-1. Exp Mol Med. 2009, 41: 171-9. doi: 10.3858/emm.2009.41.3.020.
40. Carcamo, J.M., Pedraza, A., Borquez-Ojeda, O., Zhang, B., Sanchez, R. and Golde, DW. Vitamin C is a kinase inhibitor: dehydroascorbic acid inhibits IkappaBalpha kinase beta. Mol Cell Biol. 2004, 24: 6645-52. doi: 10.1128/MCB.24.15.6645-6652.2004.
41. Trachootham, D., Lu, W., Ogasawara, M.A., Valle, N.R.-D. and Huang, P. Redox Regulation of Cell Survival. Antioxidants & Redox Signaling. 2008, 10: 1343-74. doi: 10.1089/ars.2007.1957.
42. Shi, Y. and Cheng, D. Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolism. Am J Physiol Endocrinol Metab. 2009, 297: E10-8. doi: 10.1152/ajpendo.90949.2008
43. Ho, S.Y., Delgado, L. and Storch, J. Monoacylglycerol metabolism in human intestinal Caco-2 cells: evidence for metabolic compartmentation and hydrolysis. J Biol Chem. 2002, 277: 1816-23.
44. Cenedella, R.J. and Crouthamel, WG. Intestinal versus hepatic contribution to circulating triglyceride levels. Lipids. 1974, 9: 35-42. doi: 10.1074/jbc.M108027200.
45. Ockner, R.K., Hughes, F.B. and Isselbacher, KJ. Very low density lipoproteins in intestinal lymph: origin, composition, and role in lipid transport in the fasting state. J Clin Invest. 1969, 48: 2079-88. doi: 10.1172/JCI106174.
46. Mansbach, C.M., 2nd and Gorelick, F. Development and physiological regulation of intestinal lipid absorption. II. Dietary lipid absorption, complex lipid synthesis, and the intracellular packaging and secretion of chylomicrons. Am J Physiol Gastrointest Liver Physiol. 2007, 293: G645-50. doi: 10.1152/ajpgi.00299.2007.
47. Bu, S.Y., Mashek, M.T. and Mashek, DG. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity. J Biol Chem. 2009, 284: 30474-83. doi: 10.1074/jbc.M109.036665.
48. Poppelreuther, M., Rudolph, B., Du, C., Grossmann, R., Becker, M., Thiele, C., Ehehalt, R. and Fullekrug, J. The N-terminal region of acyl-CoA synthetase 3 is essential for both the localization on lipid droplets and the function in fatty acid uptake. J Lipid Res. 2012, 53: 888-900. doi: 10.1194/jlr.M024562.
49. Lamarche, B. and Paradis, ME. Endothelial lipase and the metabolic syndrome. Curr Opin Lipidol. 2007, 18: 298-303. doi: 10.1194/jlr.M024562.
50. McCoy, M.G., Sun, G.S., Marchadier, D., Maugeais, C., Glick, J.M. and Rader, DJ. Characterization of the lipolytic activity of endothelial lipase. J Lipid Res. 2002, 43: 921-9.
51. Ishida, T., Miyashita, K., Shimizu, M., Kinoshita, N., Mori, K., Sun, L., Yasuda, T., Imamura, S., Nakajima, K., Stanhope, K.L., Havel, P.J. and Hirata, K. ELISA system for human endothelial lipase. Clin Chem. 2012, 58: 1656-64. doi: 10.1373/clinchem.2012.187914.
52. Lutton, C. and Champarnaud, G. Cholesterol synthesis and high density lipoprotein uptake are regulated independently in rat small intestinal epithelium. Gut. 1994, 35: 343-6.
53. Badellino, K.O., Wolfe, M.L., Reilly, M.P. and Rader, DJ. Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. PLoS Med. 2006, 3: e22. doi: 10.1371/journal.pmed.0030022.
54. Jin, S.H., Yang, J.H., Shin, B.Y., Seo, K., Shin, S.M., Cho, I.J. and Ki, SH. Resveratrol inhibits LXRalpha-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction. Toxicol Appl Pharmacol. 2013, 271: 95-105. doi: 10.1016/j.taap.2013.04.023.
55. Baile, C.A., Yang, J.Y., Rayalam, S., Hartzell, D.L., Lai, C.Y., Andersen, C. and Della-Fera, MA. Effect of resveratrol on fat mobilization. Ann N Y Acad Sci. 2011, 1215: 40-7. doi: 10.1111/j.1749-6632.2010.05845.x.
56. Gracia, A., Elcoroaristizabal, X., Fernandez-Quintela, A., Miranda, J., Bediaga, N.G., M, M.d.P., Rimando, A.M. and Portillo, MP. Fatty acid synthase methylation levels in adipose tissue: effects of an obesogenic diet and phenol compounds. Genes Nutr. 2014, 9: 411. doi: 10.1007/s12263-014-0411-9.
57. Alberdi, G., Rodriguez, V.M., Miranda, J., Macarulla, M.T., Arias, N., Andres-Lacueva, C. and Portillo, MP. Changes in white adipose tissue metabolism induced by resveratrol in rats. Nutr Metab (Lond). 2011, 8: 29. doi: 10.1186/1743-7075-8-29.
58. Kim, K.S., Park, S.W. and Kim, YS. Regulation of fatty acid synthase at transcriptional and post-transcriptional levels in rat liver. Yonsei Med J. 1992, 33: 199-208.
59. Katsurada, A., Iritani, N., Fukuda, H., Matsumura, Y., Nishimoto, N., Noguchi, T. and Tanaka, T. Effects of nutrients and hormones on transcriptional and post-transcriptional regulation of fatty acid synthase in rat liver. Eur J Biochem. 1990, 190: 427-33. doi: 10.1111/j.1432-1033.1990.tb15592.x.
60. Conkright, M.D., Wani, M.A., Anderson, K.P. and Lingrel, JB. A gene encoding an intestinal-enriched member of the Kruppel-like factor family expressed in intestinal epithelial cells. Nucleic Acids Res. 1999, 27: 1263-70.
61. Brey, C.W., Nelder, M.P., Hailemariam, T., Gaugler, R. and Hashmi, S. Kruppel-like family of transcription factors: an emerg ing new frontier in fat biology. Int J Biol Sci. 2009, 5: 622-36.
62. Nam, S.O., Yotsumoto, F., Miyata, K., Fukagawa, S., Yamada, H., Kuroki, M. and Miyamoto, S. Warburg effect regulated by amphiregulin in the development of colorectal cancer. Cancer Med. 2015, 4: 575-87. doi: 10.1002/cam4.416.
63. Swinnen, J.V., Heemers, H., Deboel, L., Foufelle, F., Heyns, W. and Verhoeven, G. Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway. Oncogene. 2000, 19: 5173-81.
64. Carver, R.S., Stevenson, M.C., Scheving, L.A. and Russell, WE. Diverse expression of ErbB receptor proteins during rat liver development and regeneration. Gastroenterology. 2002, 123: 2017-27. doi: 10.1053/gast.2002.37060.
65. Scheving, L.A., Tsai, T.H., Cornett, L.E., Feuers, R.J. and Scheving, LE. Circadian variation of epidermal growth factor receptor in mouse liver. Anat Rec. 1989, 224: 459-65.
66. Edwards, P.A., Muroya, H. and Gould, RG. In vivo demonstration of the circadian thythm of cholesterol biosynthesis in the liver and intestine of the rat. J Lipid Res. 1972, 13: 396-401.
67. Hems, D.A., Rath, E.A. and Verrinder, TR. Fatty acid synthesis in liver and adipose tissue of normal and genetically obese (ob/ob) mice during the 24-hour cycle. Biochem J. 1975, 150: 167-73.
68. Berrahmoune, H., Lamont, J.V., Herbeth, B., Lambert, D., Masson, C., McPhillips, M., Fitzgerald, P.S. and Visvikis-Siest, S. Association between EGF and lipid concentrations: a benefit role in the atherosclerotic process? Clin Chim Acta. 2009, 402: 196-8. doi: 10.1016/j.cca.2008.12.033.
69. Dash, S., Xiao, C., Morgantini, C., Szeto, L. and Lewis, GF. High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men. Arterioscler Thromb Vasc Biol. 2013, 33: 2895-901. doi: 10.1161/ATVBAHA.113.302342.